Related Experiment Videos

Clinical evidence of myocardial stunning in patients undergoing CABG surgery

J M Leung1

  • 1Department of Anesthesia, University of California, San Francisco-VA Medical Center 94121.

Insights

Coronary artery bypass graft (CABG) surgery can cause myocardial stunning, affecting heart function and metabolism. New imaging techniques are being developed to assess heart tissue viability after CABG.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Background:

  • Patients undergoing coronary artery bypass graft (CABG) surgery often exhibit signs of myocardial stunning.
  • Assessing regional myocardial function and perfusion post-CABG is clinically challenging.
  • Previous studies utilized left ventricular function indices to evaluate myocardial stunning after CABG.

Purpose of the Study:

  • To review the clinical manifestations and diagnostic challenges of myocardial stunning following CABG surgery.
  • To explore the metabolic and functional indicators of myocardial stunning post-CABG.
  • To discuss emerging imaging modalities for assessing myocardial viability after CABG.

Main Methods:

  • Review of existing clinical data and studies on myocardial stunning post-CABG.
  • Analysis of left ventricular function indices (cardiac index, left ventricular stroke work index, ejection fraction).
  • Examination of myocardial metabolism markers (oxygen extraction, consumption, lactate utilization).

Main Results:

  • Ventricular function changes post-CABG are reversible, consistent with myocardial stunning.
  • Depressed myocardial metabolism, including reduced oxygen extraction and lactate utilization, indicates myocardial stunning.
  • Abnormalities in regional wall motion and transient Q waves are observed in patients post-CABG.

Conclusions:

  • Myocardial stunning is a recognized complication of CABG surgery, evidenced by functional and metabolic changes.
  • Current assessment methods are limited in clinical settings.
  • Advanced imaging techniques like stress echocardiography with novel agents hold promise for differentiating viable from nonviable myocardial tissue.

Related Concept Videos